Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)

NCT04546126 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Radiotracer
Hypertension
Cholesterol

Interventions

DRUG: Dexamethasone (Group 2)
DRUG: Cosyntropin (Group 3)
COMBINATION_PRODUCT: PET/CT Scan with FNP-59

Sponsor

Benjamin Viglianti